Skip to the page

Data / Drug companies / Llorens Pharmaceutical International Division, Inc.

Llorens Pharmaceutical International Division, Inc.: 29 products in the FDA NDC directory, labeler code 54859

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Llorens Pharmaceutical International Division, Inc. (labeler code 54859) lists 29 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 29 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 1, 2025.

The request: Watch Llorens Pharmaceutical International Division, Inc. (FDA labeler code 54859): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
54859
Products in commercial distribution
29
Packages
35
Finished drugs by generic name
16
Prescription products
0
Over the counter products
29
Flagged as original packager
29 of 29 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
January 1, 1993
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs29100%

Products by type

TypeProductsShare
Over the counter drugs29100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Dextromethorphan hbr, guaifenesin467
Dextromethorphan hbr, guaifenesin, phenylephrine hcl328
Dextromethorphan, guiafenesin, pseudoephedrine hcl31
Dexbrompheniramine maleate, pseudoephedrine hcl22
Acetaminophen, dexbrompheniramine maleate23
Guaifenesin2123
Acetaminophen2214
Diphenhydramine hcl299
Lidocaine hcl248
Guaifenesin, phenylephrine hcl14
Dextromethorphan hbr, phenylephrine hcl, triprolidine hcl11
Sennosides165
Dextromethorphan, guaifenesin15
Dextromethorphan hbr, pseufoephedrine hcl, triprolidine hcl11
Pramoxine hcl, zinc oxide, calamine11
Docusate sodium179

Dosage forms

Dosage formProductsShare
Liquid2275.9%
Solution/ drops310.3%
Tablet26.9%
Suspension13.4%
Cream13.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Llorens Care Tussin DM54859-833LiquidOver the counter monograph drugsDecember 1, 2025
Llorens Care Tussin54859-510LiquidOver the counter monograph drugsDecember 1, 2025
Llorens Care Children Acetaminophen54859-850SuspensionOver the counter monograph drugsDecember 1, 2024
Allergy Relief54859-837LiquidOver the counter monograph drugsDecember 1, 2024
Conex54859-812LiquidOver the counter monograph drugsDecember 1, 2024
Conex Pediatric54859-803LiquidOver the counter monograph drugsDecember 1, 2024
Docusate Sodium Liquid54859-813LiquidOver the counter monograph drugsDecember 1, 2021
Allergy Relief54859-811LiquidOver the counter monograph drugsOctober 1, 2019
Liquid Acetaminophen54859-809LiquidOver the counter monograph drugsOctober 1, 2019
Amino Rip Muscle Pain Relief54859-415LiquidOver the counter monograph drugsOctober 1, 2019
Tusnel-DM Pediatric54859-606Solution/ dropsOver the counter monograph drugsAugust 1, 2019
Tusnel Pediatric Drops54859-605Solution/ dropsOver the counter monograph drugsAugust 1, 2019
Triponel54859-508LiquidOver the counter monograph drugsAugust 1, 2019
Senna Syrup54859-808LiquidOver the counter monograph drugsMay 1, 2019
Tusnel Pediatric DM54859-604LiquidOver the counter monograph drugsMay 1, 2019
Tusnel DM54859-517LiquidOver the counter monograph drugsMay 1, 2019
Tusnel Cough Suppressant Expectorant54859-509LiquidOver the counter monograph drugsMay 1, 2019
Tusnel EX54859-507LiquidOver the counter monograph drugsMay 1, 2019
Tusnel SF54859-506LiquidOver the counter monograph drugsMay 1, 2019
Limpia Pecho54859-011LiquidOver the counter monograph drugsMay 1, 2019
Triponel54859-514LiquidOver the counter monograph drugsMay 1, 2018
Dologesic Roll-On54859-513LiquidOver the counter monograph drugsMay 1, 2018
Dermagesic54859-202CreamOver the counter monograph drugsApril 1, 2016
Dologesic DF54859-010TabletOver the counter monograph drugsApril 1, 2016
Dologesic NF54859-001TabletOver the counter monograph drugsApril 1, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.